Similar to the acute colitis experiment, primed hADSCs, but not untreated hADSCs, treatment significantly increased the proportion of CD45RA+ B cells and decreased the number of CD4+ T cells and CD43+His48Hi neutrophils in the spleen (Fig. 4a). The gene discussed is CD4; the disease is colitis.